Sigma-Aldrich Corp. Rating Lowered to Neutral at Robert W. Baird (SIAL)
Sigma-Aldrich Corp. (NASDAQ:SIAL) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Friday, TheFlyOnTheWall.com reports. They currently have a $80.00 price objective on the stock. Robert W. Baird’s price target indicates a potential downside of 9.09% from the stock’s previous close.
Sigma-Aldrich Corp. (NASDAQ:SIAL) traded down 0.68% on Friday, hitting $87.40. The stock had a trading volume of 287,915 shares. Sigma-Aldrich Corp. has a 52 week low of $68.22 and a 52 week high of $88.55. The stock has a 50-day moving average of $84.51 and a 200-day moving average of $81.38. The company has a market cap of $10.509 billion and a price-to-earnings ratio of 22.80.
Sigma-Aldrich Corp. (NASDAQ:SIAL) last released its earnings data on Tuesday, July 23rd. The company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.01. The company had revenue of $681.00 million for the quarter, compared to the consensus estimate of $679.50 million. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, analysts predict that Sigma-Aldrich Corp. will post $4.08 earnings per share for the current fiscal year.
SIAL has been the subject of a number of other recent research reports. Analysts at Janney Montgomery Scott initiated coverage on shares of Sigma-Aldrich Corp. (NASDAQ:SIAL) in a research note to investors on Thursday, August 15th. They set a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Sigma-Aldrich Corp. (NASDAQ:SIAL) in a research note to investors on Monday, July 29th. They now have a $87.00 price target on the stock. Finally, analysts at UBS AG raised their price target on shares of Sigma-Aldrich Corp. (NASDAQ:SIAL) from $70.00 to $74.00 in a research note to investors on Wednesday, July 24th. They now have a “sell” rating on the stock.
Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $77.91.
Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.